Suchergebnisse - "Itolizumab"

PubPharm (13)

1

New Targeted Therapies for Uncontrolled Asthma

enthalten in: The journal of allergy and clinical immunology. In practice | 2019

von Corren, J.

2

Comparative efficacy and safety of thirteen biologic therapies for patients with moderate or severe psoriasis : A network meta-analysis

enthalten in: Journal of pharmacological sciences | 2019

von Xu, G. | Xia, M. | Jiang, C. | +4

3

The anti-CD6 antibody itolizumab provides clinical benefit without lymphopenia in rheumatoid arthritis patients : results from a 6-month, open-label Phase I clinical trial

enthalten in: Clinical and experimental immunology | 2018

von Rodríguez, P. | Prada, D. | Moreno, E. | +15

4

Itolizumab, a novel anti-CD6 monoclonal antibody : a safe and efficacious biologic agent for management of psoriasis

enthalten in: Expert opinion on biological therapy | 2017

von Dogra, S. | Uprety, S. | Suresh, S.

5

T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab

enthalten in: PloS one | 2017

von Bughani, U. | Saha, A. | Kuriakose, A. | +11

ErratumIn: PLoS One. 2018 Jan 30;13(1):e0192335. - PMID 29381749

6

Severe recalcitrant psoriasis treated with itolizumab, a novel anti-CD6 monoclonal antibody

enthalten in: Indian journal of dermatology, venereology and leprology | 2016

von Gupta, A. | Sharma, Y. | Deo, K. | +1

7

Itolizumab in combination with methotrexate modulates active rheumatoid arthritis : safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study

enthalten in: Clinical rheumatology | 2016

von Chopra, A. | Chandrashekara, S. | Iyer, R. | +10

8

Immunological evaluation of rheumatoid arthritis patients treated with itolizumab

enthalten in: mAbs | 2016

von Aira, L. | Hernández, P. | Prada, D. | +6

9

Therapeutic Targeting of CD6 in Autoimmune Diseases : A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab

enthalten in: Current drug targets | 2016

von Hernández, P. | Moreno, E. | Aira, L. | +1

10

Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis : A double-blind, randomized-withdrawal, placebo-controlled study

enthalten in: Journal of the American Academy of Dermatology | 2015

von Dogra, S. | D S, K. | Budamakuntla, L. | +20